abstract |
(57) [Summary] Formula I The compounds of the formula, wherein the symbols have the meanings defined in the specification, are p38 MAP kinase inhibitors and are useful for the treatment of TNFα and IL-1 mediated diseases such as rheumatoid arthritis and diseases of bone metabolism such as osteoporosis. Pharmaceutically useful. |